Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of olaparib in advanced BRCA-associated ovarian cancer
2006-006459-10Phase 2Completed
- Sponsor
- KuDOS Pharmaceuticals
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of olaparib in ovarian cancer (2 arms), sponsored by KuDOS Pharmaceuticals. Primary endpoint: Objective tumour response rate. Started Mar 2007; status: completed.
02
Drugs
olaparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2006-006459-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006459-10.